Growth differentiation factor-15 encodes a novel microRNA 3189 that functions as a potent regulator of cell death

Cell Death and Differentiation

Volumn 22, Issue 10, 2015, Pages 1641-1653

  Jones, M F ^a   Ling Li, X ^a   Subramanian, M ^a   Shabalina, Svetlana A ^b   Hara, T ^a   Zhu, Y ^a   Huang, J ^a   Yang, Y ^a   Wakefield, L M ^a   Prasanth, K V ^c   Lal, A ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 1A; GROWTH DIFFERENTIATION FACTOR 15; MICRORNA; MICRORNA 3189; PROTEIN NOXA; PROTEIN P53; UNCLASSIFIED DRUG; CELL CYCLE PROTEIN; GADD45A PROTEIN, HUMAN; GDF15 PROTEIN, HUMAN; MIRN3189 MICRORNA, HUMAN; NUCLEAR PROTEIN; TP53 PROTEIN, HUMAN;

ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER CELL; CARCINOGENICITY; CELL CYCLE REGULATION; CELL DEATH; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; DNA DAMAGE; DOWN REGULATION; GENE EXPRESSION; GENE OVEREXPRESSION; GENE SILENCING; GENETIC ASSOCIATION; HUMAN; HUMAN CELL; IN VIVO STUDY; INTRON; MOUSE; NONHUMAN; PRIORITY JOURNAL; REGULATOR GENE; TUMOR SUPPRESSOR GENE; UPREGULATION; ANIMAL; FEMALE; GENETICS; HCT 116 CELL LINE; PHYSIOLOGY; SEQUENCE ALIGNMENT; SIGNAL TRANSDUCTION;

ANIMALS; APOPTOSIS; CELL CYCLE PROTEINS; CYCLIN-DEPENDENT KINASE INHIBITOR P21; FEMALE; GENES, TUMOR SUPPRESSOR; GROWTH DIFFERENTIATION FACTOR 15; HCT116 CELLS; HUMANS; INTRONS; MICE; MICRORNAS; NUCLEAR PROTEINS; SEQUENCE ALIGNMENT; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84941172185     PISSN: 13509047     EISSN: 14765403     Source Type: Journal    
DOI: 10.1038/cdd.2015.9     Document Type: Article

References (60)

1. Wightman B, Ha I, Ruvkun G. Posttranscriptional regulation of the heterochronic gene lin-14 by lin-4 mediates temporal pattern formation in C. elegans. Cell 1993; 75: 855-862.
2. Lee RC, Feinbaum RL, Ambros V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 1993; 75: 843-854.
3. Ameres SL, Zamore PD. Diversifying microRNA sequence and function. Nat Rev Mol Cell Biol 2013; 14: 475-488.
4. Esteller M. Non-coding RNAs in human disease. Nat Rev Genet 2011; 12: 861-874.
5. Lujambio A, Lowe SW. The microcosmos of cancer. Nature 2012; 482: 347-355.
6. Kumar MS, Pester RE, Chen CY, Lane K, Chin C, Lu J et al. Dicer1 functions as a haploinsufficient tumor suppressor. Genes Dev 2009; 23: 2700-2704.
7. Jones M, Lal A. MicroRNAs, wild-type and mutant p53: more questions than answers. RNA Biol 2012; 9: 781-791.
8. Hermeking H. MicroRNAs in the p53 network: micromanagement of tumour suppression. Nat Rev Cancer 2012; 12: 613-626.
9. Leung AKL, Sharp PA. MicroRNA functions in stress responses. Mol Cell 2010; 40: 205-215.
10. Raver-Shapira N, Marciano E, Meiri E, Spector Y, Rosenfeld N, Moskovits N et al. Transcriptional activation of miR-34a contributes to p53-mediated apoptosis. Mol Cell 2007; 26: 731-743.
11. Okada N, Lin C-P, Ribeiro MC, Biton A, Lai G, He X et al. A positive feedback between p53 and miR-34 miRNAs mediates tumor suppression. Genes Dev 2014; 28: 438-450.
12. Chang T-C, Wentzel EA, Kent OA, Ramachandran K, Mullendore M, Lee KH et al. Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis. Mol Cell 2007; 26: 745-752.
13. Lal A, Thomas MP, Altschuler G, Navarro F, O'Day E, Li XL et al. Capture of microRNA-bound mRNAs identifies the tumor suppressor miR-34a as a regulator of growth factor signaling. PLoS Genet 2011; 7: e1002363.
14. Navarro F, Gutman D, Meire E, Caceres M, Rigoutsos I, Bentwich Z et al. miR-34a contributes to megakaryocytic differentiation of K562 cells independently of p53. Blood 2009; 114: 2181-2192.
15. Bohlig L, Friedrich M, Engeland K. p53 activates the PANK1/miRNA-107 gene leading to downregulation of CDK6 and p130 cell cycle proteins. Nucleic Acids Res 2011; 39: 440-453.
16. Huarte M, Guttman M, Feldser D, Garber M, Koziol MJ, Kenzelmann-Broz D et al. A large intergenic noncoding RNA induced by p53 mediates global gene repression in the p53 response. Cell 2010; 142: 409-419.
17. Park S-Y, Lee JH, Ha M, Nam J-W, Kim VN. miR-29 miRNAs activate p53 by targeting p85 alpha and CDC42. nature structural &. Mol Biol 2009; 16: 23-29.
18. Persson H, Kvist A, Rego N, Staaf J, Vallon-Christersson J, Luts L et al. Identification of new microRNAs in paired normal and tumor breast tissue suggests a dual role for the ERBB2/Her2 gene. Cancer Res 2011; 71: 78-86.
19. Stark MS, Tyagi S, Nancarrow DJ, Boyle GM, Cook AL, Whiteman DC et al. Characterization of the melanoma miRNAome by deep sequencing. PLoS ONE 2010; 5: e9685.
20. Cheng J-C, Chang H-M, Leung PCK. Wild-type p53 attenuates cancer cell motility by inducing growth differentiation factor-15 expression. Endocrinology 2011; 152: 2987-2995.
21. Bootcov MR, Bauskin AR, Valenzuela SM, Moore AG, Bansal M, He XY et al. MIC-1, a novel macrophage inhibitory cytokine, is a divergent member of the TGF-beta superfamily. Proc Natl Acad Sci USA 1997; 94: 11514-11519.
22. Friedman RC, Farh KKH, Burge CB, Bartel DP. Most mammalian mRNAs are conserved targets of microRNAs. Genome Res 2008; 19: 92-105.
23. Perdomo C, Campbell JD, Gerrein J, Tellez CS, Garrison CB, Walser TC et al. MicroRNA 4423 is a primate-specific regulator of airway epithelial cell differentiation and lung carcinogenesis. Proc Natl Acad Sci USA 2013; 110: 18946-18951.
24. Piriyapongsa J, Jordan IK. A family of human microRNA genes from miniature inverted-repeat transposable elements. PLoS One 2007; 2: e203.
25. Hu B, Ying X, Wang J, Piriyapongsa J, Jordan IK, Sheng J et al. Identification of a tumor suppressive humanspecific microRNA within the FHIT tumor suppressor gene. Cancer Res 2014; 74: 2283-94.
26. Arcila ML, Betizeau M, Cambronne XA, Guzman E, Doerflinger N, Bouhallier F et al. Novel primate miRNAs coevolved with ancient target genes in germinal zone-specific expression patterns. Neuron 2014; 81: 1255-1262.
27. Subramanian M, Francis P, Bilke S, Li XL, Hara T, Lu X et al. A mutant p53/let-7i-axis-regulated gene network drives cell migration, invasion and metastasis. Oncogene e-pub ahead of print 24 March 2014.
28. Li XL, Hara T, Choi Y, Subramanian M, Francis P, Bilke S et al. A p21-ZEB1 complex inhibits epithelial-mesenchymal transition through the microRNA 183-96-182 cluster. Mol Cell Biol 2014; 34: 533-550.
29. Thomson DW, Bracken CP, Szubert JM, Goodall GJ. On measuring miRNAs after transient transfection of mimics or antisense inhibitors. PLoS ONE 2013; 8: e55214.
30. Kim VN, Han J, Siomi MC. Biogenesis of small RNAs in animals. Nat Rev Mol Cell Biol 2009; 10: 126-139.
31. Rearick D, Prakash A, McSweeny A, Shepard SS, Fedorova L, Fedorov A. Critical association of ncRNA with introns. Nucleic Acids Res 2011; 39: 2357-2366.
32. Monteys AM, Spengler RM, Wan J, Tecedor L, Lennox KA, Xing Y et al. Structure and activity of putative intronic miRNA promoters. RNA 2010; 16: 495-505.
33. Xiao J, Lin H, Luo X, Luo X, Wang Z. miR-605 joins p53 network to form a p53:miR-605: Mdm2 positive feedback loop in response to stress. EMBO J 2011; 30: 524-532.
34. Allen MA, Andrysik Z, Dengler VL, Mellert HS, Guarnieri A, Freeman JA et al. Global analysis of p53-regulated transcription identifies its direct targets and unexpected regulatory mechanisms. Elife 2014; 3: e02200.
35. Mimeault M, Batra SK. Divergent molecular mechanisms underlying the pleiotropic functions of macrophage inhibitory cytokine-1 in cancer. J Cell Physiol 2010; 224: 626-635.
36. Djuranovic S, Nahvi A, Green R. A Parsimonious Model for Gene Regulation by miRNAs. Science 2011; 331: 550-553.
37. Li PX, Wong J, Ayed A, Ngo D, Brade AM, Arrowsmith C et al. Placental transforming growth factor-beta is a downstream mediator of the growth arrest and apoptotic response of tumor cells to DNA damage and p53 overexpression. J Biol Chem 2000; 275: 20127-20135.
38. Kelly JA, Lucia MS, Lambert JR. p53 controls prostate-derived factor/macrophage inhibitory cytokine/NSAID-activated gene expression in response to cell density, DNA damage and hypoxia through diverse mechanisms. Cancer Lett 2009; 277: 38-47.
39. Yang H, Filipovic Z, Brown D, Breit SN, Vassilev LT. Macrophage inhibitory cytokine-1: a novel biomarker for p53 pathway activation. Mol Cancer Ther 2003; 2: 1023-1029.
40. Brown DA, Ward RL, Buckhaults P, Liu T, Romans KE, Hawkins NJ et al. MIC-1 serum level and genotype: associations with progress and prognosis of colorectal carcinoma. Clin Cancer Res 2003; 9: 2642-2650.
41. Xue H, Lü B, Zhang J, Wu M, Huang Q, Wu Q et al. Identification of serum biomarkers for colorectal cancer metastasis using a differential secretome approach. J Proteome Res 2010; 9: 545-555.
42. Karan D, Chen S-J, Johansson SL, Singh AP, Paralkar VM, Lin M-F et al. Dysregulated expression of MIC-1/PDF in human prostate tumor cells. Biochem Biophys Res Commun 2003; 305: 598-604.
43. Senapati S, Rachagani S, Chaudhary K, Johansson SL, Singh RK, Batra SK. Overexpression of macrophage inhibitory cytokine-1 induces metastasis of human prostate cancer cells through the FAK-RhoA signaling pathway. Oncogene 2010; 29: 1293-1302.
44. Zhou Y, Zhong Y, Wang Y, Zhang X, Batista DL, Gejman R et al. Activation of p53 by MEG3 Non-coding RNA. J Biol Chem 2007; 282: 24731-24742.
45. Lim JH, Park J-W, Min DS, Chang J-S, Lee YH, Park YB et al. NAG-1 up-regulation mediated by EGR-1 and p53 is critical for quercetin-induced apoptosis in HCT116 colon carcinoma cells. Apoptosis 2007; 12: 411-421.
46. Baek SJ, Kim KS, Nixon JB, Wilson LC, Eling TE. Cyclooxygenase inhibitors regulate the expression of a TGF-beta superfamily member that has proapoptotic and antitumorigenic activities. Mol Pharmacol 2001; 59: 901-908.
47. Yamakuchi M, Ferlito M, Lowenstein CJ. miR-34a repression of SIRT1 regulates apoptosis. Proc Natl Acad Sci USA 2008; 105: 13421-13426.
48. Hermeking H. The miR-34 family in cancer and apoptosis. Cell Death Differ 2009; 17: 193-199.
49. Murphy M, Ahn J, Walker KK, Hoffman WH, Evans RM, Levine AJ et al. Transcriptional repression by wild-type p53 utilizes histone deacetylases, mediated by interaction with mSin3a. Genes Dev 1999; 13: 2490-2501.
50. Juan LJ, Shia WJ, Chen MH, Yang WM, Seto E, Lin YS et al. Histone deacetylases specifically down-regulate p53-dependent gene activation. J Biol Chem 2000; 275: 20436-20443.
51. Kasinski AL, Slack FJ. MicroRNAs en route to the clinic: progress in validating and targeting microRNAs for cancer therapy. Nat Rev Cancer 2011; 11: 849-864.
52. Broderick JA, Zamore PD. MicroRNA therapeutics. Gene Ther 2011; 18: 1104-1110.
53. Le MTN, Shyh-Chang N, Khaw SL, Chin L, Teh C, Tay J et al. Conserved regulation of p53 network dosage by microRNA-125b occurs through evolving miRNA-target gene pairs. PLoS Genet 2011; 7: e1002242.
54. Edgar RC. MUSCLE: a multiple sequence alignment method with reduced time and space complexity. BMC Bioinformatics 2004; 5: 113.
55. Altschul SF, Madden TL, Schäffer AA, Zhang J, Zhang Z, Miller W et al. Gapped BLASTand PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res 1997; 25: 3389-3402.
56. Karolchik D, Barber GP, Casper J, Clawson H, Cline MS, Diekhans M et al. The UCSC Genome Browser database: 2014 update. Nucleic Acids Res 2014; 42: D764-D770.
57. Tamura K, Peterson D, Peterson N, Stecher G, Nei M, Kumar S. MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods. Mol Biol Evol 2011; 28: 2731-2739.
58. Stamatakis A, Aberer AJ, Goll C, Smith SA, Berger SA, Izquierdo-Carrasco F. RAxML-Light: a tool for computing terabyte phylogenies. Bioinformatics 2012; 28: 2064-2066.
59. Ogurtsov AY, Shabalina SA, Kondrashov AS, Roytberg MA. Analysis of internal loops within the RNA secondary structure in almost quadratic time. Bioinformatics 2006; 22: 1317-1324.
60. Lorenz R, Bernhart SH, Höner Zu Siederdissen C, Tafer H, Flamm C, Stadler PF et al. ViennaRNA Package 2.0. Algorithms Mol Biol 2011; 6: 26.